WO2000058460A3 - Nouveaux composes - Google Patents

Nouveaux composes Download PDF

Info

Publication number
WO2000058460A3
WO2000058460A3 PCT/EP2000/002478 EP0002478W WO0058460A3 WO 2000058460 A3 WO2000058460 A3 WO 2000058460A3 EP 0002478 W EP0002478 W EP 0002478W WO 0058460 A3 WO0058460 A3 WO 0058460A3
Authority
WO
WIPO (PCT)
Prior art keywords
casb619
involved
colon cancers
polypeptides
cancers
Prior art date
Application number
PCT/EP2000/002478
Other languages
English (en)
Other versions
WO2000058460A2 (fr
Inventor
Claudine Elvire Marie Bruck
Jean-Pol Cassart
Thierry Coche
Y De Bassols Carlota Vinals
Original Assignee
Smithkline Beecham Biolog
Claudine Elvire Marie Bruck
Cassart Jean Pol
Thierry Coche
Y De Bassols Carlota Vinals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9907113.6A external-priority patent/GB9907113D0/en
Priority claimed from GBGB9922858.7A external-priority patent/GB9922858D0/en
Priority to HU0202930A priority Critical patent/HUP0202930A2/hu
Priority to JP2000608741A priority patent/JP2002539826A/ja
Priority to IL14504800A priority patent/IL145048A0/xx
Priority to MXPA01009688A priority patent/MXPA01009688A/es
Priority to CA002368014A priority patent/CA2368014A1/fr
Priority to KR1020017012208A priority patent/KR20020008134A/ko
Application filed by Smithkline Beecham Biolog, Claudine Elvire Marie Bruck, Cassart Jean Pol, Thierry Coche, Y De Bassols Carlota Vinals filed Critical Smithkline Beecham Biolog
Priority to EP00912627A priority patent/EP1165774A2/fr
Priority to AU34308/00A priority patent/AU3430800A/en
Priority to BR0009358-0A priority patent/BR0009358A/pt
Publication of WO2000058460A2 publication Critical patent/WO2000058460A2/fr
Publication of WO2000058460A3 publication Critical patent/WO2000058460A3/fr
Priority to NO20014629A priority patent/NO20014629L/no
Priority to HK02104691.2A priority patent/HK1044961A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des polypeptides et des polynucléotides CASB619 ainsi que des méthodes de production de ces polypeptides au moyen de techniques de recombinaison. L'invention concerne également des méthodes d'utilisation de ces polypeptides et nucléotides CASB619 dans des diagnostics, ainsi que des vaccins destinés à la prévention et au traitement des cancers, notamment les cancers des ovaires et du côlon, des maladies auto-immunes et des états pathologiques apparentés.
PCT/EP2000/002478 1999-03-26 2000-03-20 Nouveaux composes WO2000058460A2 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
AU34308/00A AU3430800A (en) 1999-03-26 2000-03-20 Novel compounds
BR0009358-0A BR0009358A (pt) 1999-03-26 2000-03-20 Compostos
EP00912627A EP1165774A2 (fr) 1999-03-26 2000-03-20 Casb619 implique dans les cancers du colon
IL14504800A IL145048A0 (en) 1999-03-26 2000-03-20 Casb619 involved in colon cancers
MXPA01009688A MXPA01009688A (es) 1999-03-26 2000-03-20 Compuestos novedosos.
CA002368014A CA2368014A1 (fr) 1999-03-26 2000-03-20 Nouveaux composes
KR1020017012208A KR20020008134A (ko) 1999-03-26 2000-03-20 화합물
HU0202930A HUP0202930A2 (en) 1999-03-26 2000-03-20 Novel compounds
JP2000608741A JP2002539826A (ja) 1999-03-26 2000-03-20 新規化合物
NO20014629A NO20014629L (no) 1999-03-26 2001-09-24 Nye forbindelser
HK02104691.2A HK1044961A1 (zh) 1999-03-26 2002-06-24 Casb619涉及結腸癌的用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9907113.6A GB9907113D0 (en) 1999-03-26 1999-03-26 Novel compounds
GB9907113.6 1999-03-26
GB9922858.7 1999-09-25
GBGB9922858.7A GB9922858D0 (en) 1999-09-25 1999-09-25 Novel compounds

Publications (2)

Publication Number Publication Date
WO2000058460A2 WO2000058460A2 (fr) 2000-10-05
WO2000058460A3 true WO2000058460A3 (fr) 2000-12-28

Family

ID=26315346

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/002478 WO2000058460A2 (fr) 1999-03-26 2000-03-20 Nouveaux composes

Country Status (17)

Country Link
EP (1) EP1165774A2 (fr)
JP (1) JP2002539826A (fr)
KR (1) KR20020008134A (fr)
CN (1) CN1351661A (fr)
AU (1) AU3430800A (fr)
BR (1) BR0009358A (fr)
CA (1) CA2368014A1 (fr)
CZ (1) CZ20013466A3 (fr)
HK (1) HK1044961A1 (fr)
HU (1) HUP0202930A2 (fr)
IL (1) IL145048A0 (fr)
MX (1) MXPA01009688A (fr)
NO (1) NO20014629L (fr)
NZ (1) NZ513839A (fr)
PL (1) PL351517A1 (fr)
TR (1) TR200102745T2 (fr)
WO (1) WO2000058460A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
FR2800388A1 (fr) * 1999-10-29 2001-05-04 Pf Medicament Clonage, expression et caracterisation d'un gene exprime dans des cellules tumorales et implique dans la regulation de la reponse immune
JP2003252801A (ja) * 2002-02-27 2003-09-10 Japan Science & Technology Corp 下垂体特異的遺伝子の使用法
JP2006517788A (ja) * 2002-12-20 2006-08-03 ミレニアム・ファーマシューティカルズ・インコーポレイテッド １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物
WO2004085666A2 (fr) * 2003-03-20 2004-10-07 Incyte Corporation Proteines secretees

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017209A1 (fr) * 1993-12-23 1995-06-29 Smithkline Beecham Biologicals (S.A.) Vaccins
WO1999006548A2 (fr) * 1997-08-01 1999-02-11 Genset Est 5' pour proteines secretees sans specificite tissulaire
WO1999054461A2 (fr) * 1998-04-17 1999-10-28 Metagen Gesellschaft Für Genomforschung Mbh Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017209A1 (fr) * 1993-12-23 1995-06-29 Smithkline Beecham Biologicals (S.A.) Vaccins
WO1999006548A2 (fr) * 1997-08-01 1999-02-11 Genset Est 5' pour proteines secretees sans specificite tissulaire
WO1999054461A2 (fr) * 1998-04-17 1999-10-28 Metagen Gesellschaft Für Genomforschung Mbh Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"ak13d08.s1 Soares_parathyroid_tumor_NbHPA Homo sapiens cDNA clone IMAGE:1405839 3', mRNA sequence", EMBL DATABASE ACCESSION NUMBER AA890726, 6 April 1998 (1998-04-06), XP002141255 *
"qo16g05.x1 NCI_CGAP_Lu5 Homo sapiens cDNA clone IMAGE:1908728 3', mRNA sequence", EMBL DATABASE ACCESSION NUMBER AI301140, 4 December 1998 (1998-12-04), XP002141256 *
"we72g04.x1 Soares_Dieckgraefe_colon_NHCD Homo sapiens cDNA clone IMAGE:2346678 3', mRNA sequence", EMBL DATABASE ACCESSION NUMBER AI672868, 19 May 1999 (1999-05-19), XP002141254 *
NAGASE, T. ET AL.: "Prediction of the coding sequences of unidentified human genes.XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro", DNA RES., vol. 7, February 2000 (2000-02-01), pages 65 - 73, XP000923011 *
OHARA, O. ET AL.: "Homo sapiens mRNA for KIAA1324 protein, partial cds", EMBL DATABASE ACCESSION NUMBER AB037745, 14 March 2000 (2000-03-14), XP002141282 *

Also Published As

Publication number Publication date
HK1044961A1 (zh) 2002-11-08
NO20014629D0 (no) 2001-09-24
CZ20013466A3 (cs) 2002-02-13
NO20014629L (no) 2001-11-26
PL351517A1 (en) 2003-04-22
TR200102745T2 (tr) 2002-05-21
CA2368014A1 (fr) 2000-10-05
EP1165774A2 (fr) 2002-01-02
AU3430800A (en) 2000-10-16
WO2000058460A2 (fr) 2000-10-05
CN1351661A (zh) 2002-05-29
JP2002539826A (ja) 2002-11-26
BR0009358A (pt) 2002-04-23
IL145048A0 (en) 2002-06-30
HUP0202930A2 (en) 2002-12-28
NZ513839A (en) 2001-09-28
KR20020008134A (ko) 2002-01-29
MXPA01009688A (es) 2002-03-27

Similar Documents

Publication Publication Date Title
WO2000053216A3 (fr) Nouvelles utilisations
EP1650221A3 (fr) Nouveaux composés
WO2000053748A3 (fr) Nouveaux composes
WO2000058460A3 (fr) Nouveaux composes
WO2001023417A3 (fr) Nouveaux composes
WO2000043509A3 (fr) Nouveaux composes
WO2002034768A3 (fr) Nouveaux composes
WO2001034795A3 (fr) Nouveaux composes
WO2003055905A3 (fr) Nouveaux composes
WO2002088361A3 (fr) Nouveaux composes
HK1047954A1 (zh) 衍生自黏膜炎莫拉氏菌的免疫源性多肽及其用途
WO2001009331A3 (fr) Nouveaux composes
WO2001009339A3 (fr) Nouveaux composes
WO2002034778A3 (fr) Nouveaux composes
WO2002066503A3 (fr) Nouveaux composes
WO2001009335A3 (fr) Nouveaux composes
WO2001009330A3 (fr) Nouveaux composes
WO2001009337A3 (fr) Nouveaux composes
WO2002032945A3 (fr) Nouveaux composes
WO2001019997A3 (fr) Nouveaux composes

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00805597.1

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 145048

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2000912627

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 513839

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2001/1295/CHE

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2368014

Country of ref document: CA

Ref document number: 2368014

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 608741

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020017012208

Country of ref document: KR

Ref document number: 34308/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/009688

Country of ref document: MX

Ref document number: PV2001-3466

Country of ref document: CZ

Ref document number: 2001/02745

Country of ref document: TR

WWP Wipo information: published in national office

Ref document number: 2000912627

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020017012208

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: PV2001-3466

Country of ref document: CZ

WWR Wipo information: refused in national office

Ref document number: PV2001-3466

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1020017012208

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 2000912627

Country of ref document: EP